CAS 1903783-48-1

Fórmula: C19H15Cl2NO3

InChI: InChI=1S/C19H15Cl2NO3/c20-13-7-8-14(21)17-16(13)19(25,18(24)22-17)9-15(23)12-5-3-11(4-6-12)10-1-2-10/h3-8,10,25H,1-2,9H2,(H,22,24)

Clave InChI: ZWHNLSHDLKIXOG-UHFFFAOYSA-N

SMILES: C1CC1C2=CC=C(C=C2)C(=O)CC3(C4=C(C=CC(=C4NC3=O)Cl)Cl)O

TK216

CAS: 1903783-48-1

TK216

Fórmula: C₁₉H₁₅Cl₂NO₃

Pureza: 97%

Peso molecular: 376.23

Ref: 54-BUP04698

TK216

CAS: 1903783-48-1

TK216 is a potent inhibitor of E26 transformation-specific (ETS) with anticancer activity.

Fórmula: C₁₉H₁₅Cl₂NO₃

Pureza: 97.22%

Forma y color: Solid

Peso molecular: 376.23

Ref: TM-T13166

4,7-Dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one

CAS: 1903783-48-1

Fórmula: C₁₉H₁₅Cl₂NO₃

Pureza: 99%

Forma y color: Solid

Peso molecular: 376.2333

Ref: IN-DA020AB4

4,7-Dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one

CAS: 1903783-48-1

4,7-Dichloro-3-(2-(4-cyclopropylphenyl)-2-oxoethyl)-3-hydroxyindolin-2-one

Fórmula: C₁₉H₁₅Cl₂NO₃

Pureza: 99%

Peso molecular: 376.23

Ref: IN-DG01163048

TK216

CAS: 1903783-48-1

TK216 is a monoclonal antibody that binds with high affinity and specificity to the leukocyte antigen CD19. TK216 is a humanized antibody that inhibits cell proliferation by inducing apoptosis, thereby inhibiting tumor growth. This drug targets CD19-expressing cells and has been shown to be effective in vitro as well as in vivo, where it has shown an inhibitory effect on xenograft tumor growth. TK216 has been evaluated in preclinical studies for its potential to treat hematologic malignancies such as leukemia and lymphoma.

Fórmula: C₁₉H₁₅Cl₂NO₃

Pureza: Min. 95%

Peso molecular: 376.2 g/mol

Ref: 3D-DBD78348